Shares of AMR Corporation (NYSE: AMR) slumped as much as 9% on Wednesday, a day after the company announced that third quarter mainline unit revenue is expected to increase between 9.8% and 10.8% year over year, and third quarter consolidated unit revenue is expected to increase between 9.8% and 10.8%. In total, Cargo and Other Revenue is anticipated to increase between 6.6% and 7.6% relative to third quarter 2009.
New York Times Company (NYSE: NYT) plunged more than 6% after it said that it expects to report a third-quarter diluted loss per share from continuing operations in the range of $.05 to $.07 per share. Excluding severance costs and the two charges listed below, diluted earnings per share are expected to be approximately $.03 to $.05 per share. The company expects total revenue to decrease approximately 2 to 3 percent. Analysts currently expect the company to earn of 5 cents, excluding items, on revenue of $565.35 million.
BSD Medical Corporation (BSDM) jumped as much as 6% after it announced that Texas Oncology has acquired the BSD-500 Hyperthermia System (BSD-500). Texas Oncology is an affiliate of the United Network of US Oncology, the nation's largest network of community-based oncologists devoted to advancing cancer care and improving the cancer patient experience.
Full Disclosure: None.
New York Times Company (NYSE: NYT) plunged more than 6% after it said that it expects to report a third-quarter diluted loss per share from continuing operations in the range of $.05 to $.07 per share. Excluding severance costs and the two charges listed below, diluted earnings per share are expected to be approximately $.03 to $.05 per share. The company expects total revenue to decrease approximately 2 to 3 percent. Analysts currently expect the company to earn of 5 cents, excluding items, on revenue of $565.35 million.
BSD Medical Corporation (BSDM) jumped as much as 6% after it announced that Texas Oncology has acquired the BSD-500 Hyperthermia System (BSD-500). Texas Oncology is an affiliate of the United Network of US Oncology, the nation's largest network of community-based oncologists devoted to advancing cancer care and improving the cancer patient experience.
Full Disclosure: None.
